Lung cancer is the leading cause of cancer-related mortality in the United States and
worldwide. Early detection of lung cancer is an important opportunity for decreasing …

This guideline is based on a comprehensive review of the literature on pulmonary nodules
and expert opinion. Although the management pathway for the majority of nodules detected …

Lung cancer remains the leading cause of cancer related deaths worldwide. Lung cancer
screening using low-dose computed tomography (LDCT) has been shown to reduce lung …

Lung cancer continues to be a major global health problem; the disease is diagnosed in
more than 1.6 million new patients each year. However, significant progress is underway in …

In daily clinical practice, radiologists and pulmonologists are faced with incidental
radiographic findings of pulmonary nodules. Deciding how to manage these findings is very …

Background Estimation of the risk of malignancy in pulmonary nodules detected by CT is
central in clinical management. The use of artificial intelligence (AI) offers an opportunity to …

Rationale: The management of indeterminate pulmonary nodules (IPNs) remains
challenging, resulting in invasive procedures and delays in diagnosis and treatment …

The British Thoracic Society guideline for the investigation and management of pulmonary
nodules is published as a supplement to this edition of the journal. It provides …

Lung cancer screening with low-dose computed tomography can reduce death from lung
cancer by 20–24% in high-risk smokers. National lung cancer screening programmes have …

Background Large lung nodules (≥ 15 mm) have the highest risk of malignancy, and may
exhibit important differences in phenotypic or clinical characteristics to their smaller …